06
For Micrel (medical technology) incomplete FTO analysis and underdeveloped IP strategy in the past lead to significant loss in UK market share.
For Micrel (medical technology) incomplete FTO analysis and underdeveloped IP strategy in the past lead to significant loss in UK market share.